4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-346942
Chief Development Officer sold 16,300 shares at an average $113.43 ($1,848,890)
- Chief Development Officer acquired 16,300 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Guyer William · Chief Development Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,300 | $21.65 | $352,895 | 20,285 | D |
| 2026-08-10 | Sale : show line 2 in the form 10b5-1 | −11,530 | $113.18 | $1,304,933 | 8,755 | D |
| 2026-08-10 | Sale : show line 3 in the form 10b5-1 | −4,770 | $114.04 | $543,957 | 3,985 | D |
| Open-market sales · 16,300 sh · avg $113.43 · $1,848,890 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −16,300 | 110,000 | D |
Loading xslF345X06/ownership.xml…